Researchers investigate the excess mortality associated with tropical cyclones in the contiguous United States.
GSK reworks CureVac deal, paying $429M upfront to grab control of mRNA flu and Covid vaccines
Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS